Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - DEPRECIATION & AMORTIZATION
Depreciation & Amortization FATE - Fate Therapeutics, Inc.
18.3 M
LAST VALUE
76.78%
2 YEAR CAGR
72.30%
5 YEAR CAGR
41.43%
10 YEAR CAGR